Clinical Trial

Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

Study acronym: DRAPE
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension. The main questions it aims to answer are: Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-23; most recent amendment 2025-06-17.
Status change: Not Yet Recruiting → Recruiting 2025-06-17
Trial Details
NCT Number NCT06386185
Lead Sponsor Royal United Hospitals Bath NHS Foundation Trust
Collaborators: Sheffield Teaching Hospitals NHS Foundation Trust, Royal Free Hospital NHS Foundation Trust, Golden Jubilee National Hospital, Papworth Hospital NHS Foundation Trust, University of Bath
Conditions Pulmonary Hypertension
Enrollment 2,500 participants
Start Date 2024-09-06
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-18